Accelerated versus standard corneal collagen cross-linking in pediatric keratoconus patients: 24 months follow-up results
- PMID: 29910023
- DOI: 10.1016/j.clae.2018.06.001
Accelerated versus standard corneal collagen cross-linking in pediatric keratoconus patients: 24 months follow-up results
Abstract
Purpose: To compare the 24 month visual, refractive, topographic and aberrometric results of the accelerated and standard corneal collagen cross-linking (CXL) in pediatric keratoconus patients.
Methods: 87 eyes of 64 consecutive keratoconus patients under 18 years old with 24 month follow-up period following standard or accelerated CXL were included. 38 eyes received standard CXL (3 Mw/cm2, 30 min), while 49 eyes had accelerated CXL (9 mW/cm2, 10 min). Changes in the uncorrected (UCVA) and best corrected visual acuity (BCVA), spherical equivalent (SE), manifest astigmatism (MA), corneal topographic parameters, and corneal aberrations such as spherical aberration (SA), high order aberrations (HOAs), horizontal and vertical coma were evaluated. Corneal haze was graded and progression rate was assessed.
Results: The difference between baseline and 24 months postoperative UCVA, BCVA, SimK (keratometry)-1, SimK-2, Kmax, and the corneal aberrations were not significantly different between the two groups (p > 0.05 for all). The mean reduction in thinnest corneal pachymetry from baseline to 24 months after CXL was higher in accelerated CXL group (p = 0.007). The progression rate was 13.1% in standard and 16.3% in accelerated group (p = 0.754). There were no differences in the grade of corneal haze between the two groups (p = 0.249). No complications were observed in the both groups.
Conclusion: The 24 month results of accelerated and standard CXL revealed that, the efficacy and safety of accelerated CXL were the same with standard CXL in pediatric keratoconus patients. As being a rapid procedure, accelerated CXL appears to be more benefical for pediatric patients.
Keywords: Accelerated collagen cross-linking; Efficacy; Pediatric keratoconus; Safety.
Copyright © 2018 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Prospective, randomized contralateral eye study of accelerated and conventional corneal cross-linking in pediatric keratoconus.Int Ophthalmol. 2019 May;39(5):971-979. doi: 10.1007/s10792-018-0898-y. Epub 2018 Mar 21. Int Ophthalmol. 2019. PMID: 29564806 Clinical Trial.
-
Optical Performance of the Cornea One Year Following Keratoconus Treatment with Corneal Collagen Cross-Linking.Curr Eye Res. 2018 Dec;43(12):1415-1421. doi: 10.1080/02713683.2018.1501802. Epub 2018 Jul 30. Curr Eye Res. 2018. PMID: 30012019
-
Risk factors for keratoconus progression after treatment by accelerated cross-linking (A-CXL): A prospective 24-month study.J Fr Ophtalmol. 2021 Jun;44(6):863-872. doi: 10.1016/j.jfo.2020.08.040. Epub 2021 May 28. J Fr Ophtalmol. 2021. PMID: 34059330
-
Corneal collagen cross-linking: a review of 1-year outcomes.Eye Contact Lens. 2014 Nov;40(6):345-52. doi: 10.1097/ICL.0000000000000094. Eye Contact Lens. 2014. PMID: 25343263 Review.
-
Comparison of standard and accelerated corneal cross-linking for the treatment of keratoconus: a meta-analysis.Acta Ophthalmol. 2019 Feb;97(1):e22-e35. doi: 10.1111/aos.13814. Epub 2018 May 31. Acta Ophthalmol. 2019. PMID: 29855152 Review.
Cited by
-
Corneal collagen cross-linking epithelium-on vs. epithelium-off: a systematic review and meta-analysis.Eye Vis (Lond). 2021 Sep 1;8(1):34. doi: 10.1186/s40662-021-00256-0. Eye Vis (Lond). 2021. PMID: 34565473 Free PMC article. Review.
-
Outcomes of accelerated collagen cross linking in progressive paediatric keratoconus.Indian J Ophthalmol. 2023 May;71(5):1889-1893. doi: 10.4103/ijo.IJO_1469_22. Indian J Ophthalmol. 2023. PMID: 37203050 Free PMC article.
-
Comparative Results Between "Epi-Off" Accelerated and "Epi-Off" Standard Corneal Collagen Crosslinking-UVA in Progressive Keratoconus - 7 Years of Follow-Up.Ther Clin Risk Manag. 2021 Sep 7;17:975-988. doi: 10.2147/TCRM.S321410. eCollection 2021. Ther Clin Risk Manag. 2021. PMID: 34522101 Free PMC article.
-
Effectiveness and safety of accelerated (9 mW/cm2) corneal collagen cross-linking for progressive keratoconus: a 24-month follow-up.Eye (Lond). 2019 May;33(5):812-818. doi: 10.1038/s41433-018-0323-9. Epub 2019 Jan 4. Eye (Lond). 2019. PMID: 30610230 Free PMC article.
-
Comparative 2-year outcomes of conventional and accelerated corneal collagen crosslinking in progressive keratoconus.Int J Ophthalmol. 2020 Aug 18;13(8):1223-1230. doi: 10.18240/ijo.2020.08.07. eCollection 2020. Int J Ophthalmol. 2020. PMID: 32821675 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials